These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 12494164)
1. [Long term use of a non-selective beta-blocker with vasodilating properties carvedilol in patients with severe heart failure]. Zaikin SY; Iosava IK; Vasechkin SS; Gruzdev AK; Sidorenko BA Kardiologiia; 2002; 42(4):33-6. PubMed ID: 12494164 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433 [TBL] [Abstract][Full Text] [Related]
3. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. Packer M; Bristow MR; Cohn JN; Colucci WS; Fowler MB; Gilbert EM; Shusterman NH N Engl J Med; 1996 May; 334(21):1349-55. PubMed ID: 8614419 [TBL] [Abstract][Full Text] [Related]
4. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol in the treatment of chronic heart failure. Moe G Expert Opin Pharmacother; 2001 May; 2(5):831-43. PubMed ID: 11336626 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. Cohn JN; Fowler MB; Bristow MR; Colucci WS; Gilbert EM; Kinhal V; Krueger SK; Lejemtel T; Narahara KA; Packer M; Young ST; Holcslaw TL; Lukas MA J Card Fail; 1997 Sep; 3(3):173-9. PubMed ID: 9330125 [TBL] [Abstract][Full Text] [Related]
7. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S; Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332 [TBL] [Abstract][Full Text] [Related]
8. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy. Tatli E; Kurum T Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561 [TBL] [Abstract][Full Text] [Related]
9. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462 [TBL] [Abstract][Full Text] [Related]
10. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol. Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524 [TBL] [Abstract][Full Text] [Related]
11. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol in severe heart failure. Fowler MB Am J Cardiol; 2004 May; 93(9A):35B-9B. PubMed ID: 15144935 [TBL] [Abstract][Full Text] [Related]
12. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life? Fowler MB Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708 [TBL] [Abstract][Full Text] [Related]
13. Carvedilol in heart failure. Kelly DT Cardiology; 1993; 82 Suppl 3():45-9. PubMed ID: 8106165 [TBL] [Abstract][Full Text] [Related]
14. Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockers. Vittorio TJ; Lang CC; Katz SD; Packer M; Mancini DM; Jorde UP Circulation; 2003 Jan; 107(2):290-3. PubMed ID: 12538430 [TBL] [Abstract][Full Text] [Related]
15. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653 [TBL] [Abstract][Full Text] [Related]
16. Baseline predictors of tolerability to carvedilol in patients with chronic heart failure. Krum H; Ninio D; MacDonald P Heart; 2000 Dec; 84(6):615-9. PubMed ID: 11083738 [TBL] [Abstract][Full Text] [Related]
17. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy with carvedilol and amiodarone in patients with severe heart failure. Nägele H; Bohlmann M; Eck U; Petersen B; Rödiger W Eur J Heart Fail; 2000 Mar; 2(1):71-9. PubMed ID: 10742706 [TBL] [Abstract][Full Text] [Related]
19. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure. Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014 [TBL] [Abstract][Full Text] [Related]
20. Value of carvedilol in congestive heart failure secondary to coronary artery disease. Das Gupta P; Broadhurst P; Raftery EB; Lahiri A Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]